Critical Limb Ischemia Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope

Critical limb ischemia treatment refers to re-establishing blood flow to the area affected with critical limb ischemia, a chronic condition where blood flow to one or two of the hands, and legs are severely blocked causing numbness and pain. Treatment includes diagnosis and treating patients by medication, surgery using devices, and others.

Sizing and Forecast

The critical limb ischemia market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increase in diabetes cases, tobacco consumption, hypertension prevalence, improvements in vascular imaging, growth in endovascular interventions, medical research and clinical trials..

The critical limb ischemia market size is expected to see strong growth in the next few years. It will grow to $5.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to regenerative medicine advances, focus on early intervention, increasing prevalence of obesity, global health initiatives, patient education program.. Major trends in the forecast period include wearable health technologies, telemedicine and remote patient monitoring, integration of artificial intelligence (ai), patient-centric care models, minimally invasive interventions..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report

Segmentation & Regional Insights

The critical limb ischemia market covered in this report is segmented –

1) By Type: Devices, Drugs, Surgery
2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications
3) By Application: Hospital, Clinic, Other Applications

North America was the largest region in the critical limb ischemia treatment market in 2023. The regions covered in the critical limb ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp

Major Driver Impacting Market Growth

The rising incidence of diabetes mellitus and peripheral artery diseases is expected to propel the growth of the critical limb ischemia treatment market going forward. Diabetes mellitus refers to a metabolic disease condition that involves elevated levels of blood glucose. Peripheral artery disease refers to a condition where leg arteries are narrowed, reducing blood flow to the arms or legs. The likelihood of vascular complications and amputation is increased by diabetes and peripheral artery diseases, making them risk factors for causing critical limb ischemia. Therefore, the rising incidence of diabetes mellitus and peripheral artery diseases is driving the growth of the critical limb ischemia market. For instance, in January 2022, according to the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, the global diabetes prevalence in 20–79-year-olds in 2021 was 536.6 million and was expected to increase by 12.2% (783.2 million) in 2045. Furthermore, in March 2023, according to the journal published by Oxford University Press, a UK-based university press of the University of Oxford, more than 200 million people were affected by peripheral artery diseases in 2020, and it is expected to increase by nearly 50% by 2045. Therefore, the growing adoption of cloud-based document processing services is driving the critical limb ischemia treatment market.

Key Industry Players

Major companies operating in the critical limb ischemia market are focused on introducing innovative solutions, such as a clinically engineered solution for immobilizing the patient’s leg, to gain a competitive edge in the market. Such solutions gently immobilize the patient’s leg during fluoroscopy-guided treatment, providing pressure management for patients who often suffer from painful ulcerations. For instance, in January 2022, Adept Medical, a New Zealand-based manufacturer of medical equipment suites, launched its Lower Leg Support, designed to gently immobilize a patient’s leg during fluoroscopy-guided treatment of critical limb ischemia. With its ability to do both endorotation and exorotation, the Lower Leg Support allows for many positioning possibilities while gently maintaining the foot in a slightly plantar flexed posture to facilitate imaging. The ergonomic design of the gadget arranges the leg to meet the necessary procedural requirements for procedures involving the lower limb. One of the gadget’s features is a changeable footplate, which lets users use it on either the left or right foot. If foot manipulation is necessary during the procedure, the footplate can be completely removed to allow for distal artery access, ultrasound imaging, and pressure management for patients who frequently experience painful ulcerations. Additionally, soft foam straps that gently immobilize patients during conscious sedation are also available.

The critical limb ischemia market report table of contents includes:

1. Executive Summary

2. Critical Limb Ischemia Market Characteristics

3. Critical Limb Ischemia Market Trends And Strategies

4. Critical Limb Ischemia Market – Macro Economic Scenario

 

5. Global Critical Limb Ischemia Market Size and Growth
….

31. Global Critical Limb Ischemia Market Competitive Benchmarking

32. Global Critical Limb Ischemia Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Critical Limb Ischemia Market

34. Critical Limb Ischemia Market Future Outlook and Potential Analysis

35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model